Application due dates on or after February 5, 2022 and subsequent receipt dates through January 7, 2023.
This Notice of Special Interest is a re-issue of NOT-AR-21-012.
The purpose of this Notice is to announce to potential applicants to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) an interest in research on the impact of COVID-19 as related to diseases and conditions within the NIAMS mission.
Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Co-Morbidities, Asthma, Cancer, Cardiovascular Disease, Cirrhosis, COVID-19, Diabetes, Immune Disorders, Inflammation, Rheumatoid Disorders, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Health Disparities, Healthcare Implementation, Organ, Endocrine, Skin, Social Determinants of Health, Treatments, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets, Anti-viral Targets, Immunological Response Targets, Drugs, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Vaccine Hesitancy